Johnson & Johnson (J&J) has set aside $5.5 billion in an effort to resolve tens of thousands of lawsuits in the United States alleging that its talcum powder-based products caused ovarian cancer.
The proposed settlement is intended to address claims brought by individuals who allege that long-term use of the company’s talc-based products resulted in serious health complications, including ovarian cancer. Johnson & Johnson has consistently maintained that its talc products are safe and that decades of scientific research do not support claims that they cause cancer.
The legal battle has spanned years and become one of the largest product liability cases in U.S. history, involving thousands of plaintiffs and multiple court proceedings.
While the company has reserved billions of dollars for the proposed resolution, the settlement still requires legal approval and may face objections from some claimants and attorneys involved in the litigation.
In recent years, Johnson & Johnson discontinued sales of its talc-based baby powder in several markets and transitioned to a cornstarch-based formula, citing changing consumer demand and ongoing litigation rather than admitting any wrongdoing.
The outcome of the proposed settlement could bring closure to many of the pending lawsuits while continuing to shape how major corporations address mass tort litigation involving consumer health products.
